Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Diabetes > Opportunities Assessment for Diabetes Therapeutics Market-Taiwan
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Opportunities Assessment for Diabetes Therapeutics Market-Taiwan

Published by Frost & Sullivan
Published December, 2008 Product code 79125
Content info 39 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Opportunities Assessment for Diabetes Therapeutics Market-Taiwan published by Frost & Sullivan in December, 2008. This report consists of 39 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Taiwan.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • Executive Summary

2. DIABETES THERAPEUTICS MARKET

Market Overview

  • Introduction
  • Context for the Study
  • Research Service Scope and Segmentation
  • Methodology
  • Restraints in Forecasts

3. TAIWANESE DIABETES THERAPEUTICS MARKET

Market Overview

  • Introduction
  • Market Engineering Measurements
  • Government Initiatives
  • Listing Drugs Under the Government Reimbursement Plan

Market Forecasts and Trends

  • Patient Forecasts
  • Cost of Treatment

Treatment and Diagnosis

  • Key Treaters
  • Diagnostic Tests
  • Treatment Options
  • Treatment Practice and Glycemic Control
  • Use of Insulin
  • Key Factors/Drivers to Prescribe Insulin
  • Duration of Treatment
  • Product Share by Endocrinologists and GPS
  • Product/Class Launches in 2007 and in future
  • Clinical Trials

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis
  • Future Trends
  • Challenges Faced by Physicians

4. APPENDIX

Taiwan

  • Taiwan
Back to Top